Schaper Benz & Wise Investment Counsel Inc. WI Sells 48,265 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Schaper Benz & Wise Investment Counsel Inc. WI lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 175,949 shares of the pharmacy operator’s stock after selling 48,265 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Walgreens Boots Alliance were worth $1,642,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of WBA. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co lifted its holdings in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after buying an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $28,000. Finally, TD Private Client Wealth LLC lifted its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares during the period. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of several analyst reports. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Finally, Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $11.39 on Friday. The business’s 50-day moving average is $10.64 and its two-hundred day moving average is $9.72. The company has a market capitalization of $9.84 billion, a P/E ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm earned $0.66 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. Research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.